Suppr超能文献

在大鼠强迫游泳试验中,去甲肾上腺素能系统介导的相互作用可能会阻止某些亚急性抗抑郁治疗的5-羟色胺特性的表达。

In the rat forced swimming test, NA-system mediated interactions may prevent the 5-HT properties of some subacute antidepressant treatments being expressed.

作者信息

Rénéric Jean-Philippe, Bouvard Manuel, Stinus Luis

机构信息

Laboratoire de Neuropsychobiologie des Désadaptations, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5541, BP31, Université Bordeaux 2, 146 Rue Léo Saignat, 33076 Bordeaux Cedex, France.

出版信息

Eur Neuropsychopharmacol. 2002 Apr;12(2):159-71. doi: 10.1016/s0924-977x(02)00007-x.

Abstract

In the rat forced swimming test (FST), reuptake inhibitors selective of either serotonin (5-HT) or noradrenaline (NA) decrease immobility duration, and increase, respectively, swimming and climbing behaviour. In this study, an almost total 6-OHDA-induced NA-depletion prevented the behavioural effects of desipramine, but not fluoxetine. Interestingly, the serotonin/noradrenaline-reuptake-inhibitor milnacipran, as well as a (desipramine+fluoxetine) combination, could produce both swimming and climbing behaviour in NA-lesioned rats, but not in non-lesioned. The new antidepressant mirtazapine, which enhances both 5-HT and NA transmissions, supposedly through the antagonizing of alpha(2)-adrenoreceptors, dose-dependently reduced immobility and increased climbing behaviour. Interestingly, a (mirtazapine+fluoxetine) combination treatment resulted in additive anti-immobility effects and in the summation of fluoxetine-induced swimming with mirtazapine-induced climbing. Taken together, these data suggest that the NA system mediates presynaptic inhibiting interactions on the 5-HT system, that may involve alpha(2)-receptors, and that may limit the efficacy of mixed serotonin/noradrenaline reuptake inhibition in subacute antidepressant treatments.

摘要

在大鼠强迫游泳试验(FST)中,选择性作用于5-羟色胺(5-HT)或去甲肾上腺素(NA)的再摄取抑制剂可减少不动时间,并分别增加游泳和攀爬行为。在本研究中,几乎完全由6-羟基多巴胺(6-OHDA)诱导的NA耗竭可阻止地昔帕明的行为效应,但对氟西汀无效。有趣的是,5-羟色胺/去甲肾上腺素再摄取抑制剂米氮平,以及(地昔帕明+氟西汀)联合用药,可在NA损伤的大鼠中产生游泳和攀爬行为,但在未损伤的大鼠中则不能。新型抗抑郁药米氮平,可增强5-HT和NA的传递,推测是通过拮抗α2-肾上腺素能受体,剂量依赖性地减少不动行为并增加攀爬行为。有趣的是,(米氮平+氟西汀)联合治疗产生了相加的抗不动效应,且氟西汀诱导的游泳行为与米氮平诱导的攀爬行为相加。综上所述,这些数据表明,NA系统介导了对5-HT系统的突触前抑制性相互作用,这可能涉及α2受体,并且可能限制了5-羟色胺/去甲肾上腺素混合再摄取抑制在亚急性抗抑郁治疗中的疗效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验